Creating a continuum of care: Integrating obstetricians and gynecologists in the care of young cancer patients

Clinical Obstetrics and Gynecology

Volumn 54, Issue 4, 2011, Pages 619-632

  Kong, Betty Y ^a   Skory, Robin M ^a   Woodruff, Teresa K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

cancer; fertility preservation; gynecology; obstetrics; oncofertility; pregnancy

Indexed keywords

BENDAMUSTINE; BUSULFAN; CARBOPLATIN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOCETAXEL; IFOSFAMIDE; LOMUSTINE; MELPHALAN; NAVELBINE; NEDAPLATIN; NIMUSTINE; OXALIPLATIN; PREDNIMUSTINE; PROCARBAZINE; SATRAPLATIN; SEMUSTINE; STREPTOZOCIN; TEMOZOLOMIDE; TREOSULFAN; TRIAZIQUONE; TRIPLATIN TETRANITRATE; TROFOSFAMIDE; UNINDEXED DRUG; URAMUSTINE; VINBLASTINE;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CANCER THERAPY; CRYOPRESERVATION; DRUG SAFETY; EMBRYO TRANSFER; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GYNECOLOGY; HODGKIN DISEASE; HUMAN; INTERPERSONAL COMMUNICATION; IONIZING RADIATION; MELANOMA; NEOPLASM; OBSTETRICS; OOCYTE MATURATION; OVARIAN RESERVE; OVARY HYPERSTIMULATION; PATIENT CARE; PREMATURE OVARIAN FAILURE; REPRODUCTIVE HEALTH; REPRODUCTIVE TOXICITY; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; CONTINUITY OF PATIENT CARE; FEMALE; FERTILITY; FERTILITY PRESERVATION; GYNECOLOGY; HUMANS; INTERDISCIPLINARY COMMUNICATION; MEDICAL ONCOLOGY; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; REPRODUCTIVE MEDICINE;

EID: 80055099521     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e318236ea2c     Document Type: Article

References (44)

1. Altekruse SFKC, Krapcho M, Neyman N, SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/ 1975-2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
2. Woodruff TK. The Oncofertility Consortium-addressing fertility in young people with cancer. Nat Rev Clin Oncol. 2010;7:466-475.
3. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917-2931. (Pubitemid 46655598)
4. Ethics Committee of the American Society for Reproductive Medicine.Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83:1622-1628.
5. De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet. 2010; 376:911-921.
6. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004;10:251-266.
7. Rosendahl M, Andersen CY, la Cour Freiesleben N, et al. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. Fertil Steril. 2010;94:156-166.
8. Broekmans FJ, Visser JA, Laven JS, et al. Anti-Mullerian hormone and ovarian dysfunction. Trends Endocrinol Metab. 2008;19:340-347.
9. Perez GI, Knudson CM, Leykin L, et al. Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nat Med. 1997;3:1228-1232. (Pubitemid 27508823)
10. Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol. 2000;169:123-131. (Pubitemid 32063311)
11. Adriaens I, Smitz J, Jacquet P. The current knowledge on radiosensitivity of ovarian follicle development stages. Hum Reprod Update. 2009;15:359-377.
12. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18:117-121. (Pubitemid 36138861)
13. Wallace WH, Shalet SM, Crowne EC, et al. Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin Oncol (R Coll Radiol). 1989;1:75-79.
14. Wallace WH, Thomson AB, Saran F, et al. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62:738-744. (Pubitemid 40779763)
15. Critchley HO, Bath LE, Wallace WH. Radiation damage to the uterus-review of the effects of treatment of childhood cancer. Hum Fertil (Camb). 2002;5:61-66. (Pubitemid 34624867)
16. Holm K, Nysom K, Brocks V, et al. Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation in childhood. Bone Marrow Transplant. 1999;23:259-263. (Pubitemid 29078339)
17. Constine LS, Woolf PD, Cann D, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med. 1993;328:87-94.
18. Bath LE, Anderson RA, Critchley HO, et al. Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. Hum Reprod. 2001;16: 1838-1844. (Pubitemid 32916209)
19. Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360:902-911.
20. Loutradi KE, Kolibianakis EM, Venetis CA, et al. Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysis. Fertil Steril. 2008;90:186-193. (Pubitemid 351885199)
21. McLernon DJ, Harrild K, Bergh C, et al. Clinical effectiveness of elective single versus double embryo transfer: metaanalysis of individual patient data from randomised trials. BMJ. 2010;341:c6945.
22. Woodruff TK, Zoloth L, Campo-Engelstein L, et al. Oncofertility: Ethical, Legal, Social, and Medical Perspectives. Boston: Springer, 2010.
23. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009; 18:769-776.
24. Donnez J, Silber S, Andersen CY, et al. Children born after autotransplantation of cryopreserved ovarian tissue.Areview of 13 live births. Ann Med. 2011;43:437-450.
25. Xu M, Kreeger PK, Shea LD, et al. Tissueengineered follicles produce live, fertile offspring. Tissue Eng. 2006;12:2739-2746. (Pubitemid 46141242)
26. Terenziani M, Piva L, Meazza C, et al. Oophoropexy: a relevant role in preservation of ovarian function after pelvic irradiation. Fertil Steril. 2009;91: 935 e15-935 e16.
27. Gareer W, Gad Z, Gareer H. Needle oophoropexy: a new simple technique for ovarian transposition prior to pelvic irradiation. Surg Endosc. 2011;25: 2241-2246.
28. Kroman N, Jensen M-B, Wohlfahrt J, et al. Pregnancy after treatment of breast cancer-a population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol. 2008;47:545-549. (Pubitemid 351878435)
29. Ives A, Saunders C, Bulsara M, et al. Pregnancy after breast cancer: population based study. BMJ. 2007;334:194-198.
30. Bar J, Davidi O, Goshen Y, et al. Pregnancy outcome in women treated with doxorubicin for childhood cancer. Am J Obstet Gynecol. 2003;189:853-857. (Pubitemid 37194121)
31. Signorello LB, Mulvihill JJ, Green DM, et al. Stillbirth and neonatal death in relation to radiation exposure before conception: a retrospective cohort study. Lancet. 2010;376:624-630.
32. Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol. 2005;23:276-292. (Pubitemid 46206879)
33. Winther JF, Boice JD, Mulvihill JJ, et al. Chromosomal abnormalities among offspring of childhood-cancer survivors in Denmark: a population-based study. Am J Hum Genet. 2004;74:1282-1285. (Pubitemid 38669328)
34. Boice JD Jr, Tawn EJ, Winther JF, et al. Genetic effects of radiotherapy for childhood cancer. Health Phys. 2003;85:65-80. (Pubitemid 36706042)
35. Sutcliffe SB. Treatment of neoplastic disease during pregnancy: maternal and fetal effects. Clin Invest Med. 1985;8:333-338. (Pubitemid 16182993)
36. Doll DC, Ringenberg QS, Yarbro JW. Management of cancer during pregnancy. Arch Intern Med. 1988;148:2058-2064.
37. Cardonick E, Usmani A, Ghaffar S. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol. 2010;33:221-228.
38. vanKalken CK, GiacconeG, van der Valk P, et al. Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am J Pathol. 1992;141:1063-1072.
39. Andersson TM, Johansson AL, Hsieh CC, et al. Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol. 2009;114:568-572.
40. Loibl S, von Minckwitz G, Gwyn K, et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer. 2006;106: 237-246. (Pubitemid 43100430)
41. LethabyAE,O'NeillMA, MasonBH, et al. Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group. Int J Cancer. 1996;67:751-755. (Pubitemid 26348801)
42. Ishida T, Yokoe T, Kasumi F, et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res. 1992;83:1143-1149. (Pubitemid 23009034)
43. Bonnier P,Romain S, Dilhuydy JM, et al. Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de PathologieMammaire Study Group. Int JCancer. 1997;72:720-727. (Pubitemid 27431510)
44. Hahn KM, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006; 107:1219-1226. (Pubitemid 44452769)